Stay updated on Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page.

Latest updates to the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page
- Check4 days agoChange DetectedA banner announces NIH website updates and notes that some content is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check18 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedLinked study documents such as the Statistical Analysis Plan and Study Protocol, as well as the comprehensive Locations content and eligibility context, were removed from the page, reducing visibility of regulatory materials and site lists for this CVL-231 schizophrenia trial.SummaryDifference19%

- Check39 days agoChange DetectedThe page gains the keyword 'Schizophrenia' and a related topics entry for MedlinePlus Genetics. The revision tag updates from v3.6.6 to v3.7.0, indicating a minor page version upgrade.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a newer release of the site’s code. This appears to be a maintenance/versioning change with no impact on the displayed study details or content.SummaryDifference0.0%

Stay in the know with updates to Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page.